NEW YORK, July 26, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:Global Biochips Industry
This report analyzes the worldwide markets for Biochips in US$ Million by the following Product Segments: DNA Chips, Protein Chips, and Lab Chips. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Middle East, and Latin America. The report profiles 77 companies including many key and niche players such as Affymetrix Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Caliper Life Sciences, Inc., Cepheid Inc., Fluidigm Corporation, GE Healthcare Ltd., Illumina, Inc., Life Technologies Corporation, Ocimum Biosolutions Ltd., Takara Bio, Inc., Clontech Laboratories, Inc., and Zyomyx, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-3Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3A. DNA Chips I-3B. Protein Chips I-4C. Lab Chips I-4II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
A Primer II-1
Recession Dries Up Funds for Biotech Firms II-1
Promising Biochips Promote Biological Research II-2
Key Forces Driving the Industry II-3
DNA Chips Lead the Application Front II-3
Copyright©2012 PR Newswire.
All rights reserved